Waterfront Wealth Inc. Aslan Pharmaceuticals LTD Transaction History

Waterfront Wealth Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	SELL	$0.36 - $24.24 $28,341 - $1.91 Million	-78,725 Reduced 21.84%	281,775 $101,000
Q3 2022 Nov 01, 2022	BUY	$0.42 - $24.68 $3,150 - $185,100	7,500 Added 2.12%	360,500 $156,000
Q2 2022 Jul 25, 2022	BUY	$0.36 - $0.9 $8,640 - $21,600	24,000 Added 7.29%	353,000 $175,000
Q1 2022 May 13, 2022	BUY	$0.74 - $1.22 $43,660 - $71,980	59,000 Added 21.85%	329,000 $270,000
Q4 2021 Feb 14, 2022	BUY	$1.11 - $1.86 $299,700 - $502,200	270,000 New	270,000 $302,000

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Waterfront Wealth Inc., based on Form 13F filings with the SEC.

Stay updated on Waterfront Wealth Inc. with notifications on news.